Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cyclooxygenase 2 Inhibitor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cyclooxygenase 2 Inhibitormarket, defines the market attractiveness level of Cyclooxygenase 2 Inhibitor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cyclooxygenase 2 Inhibitor industry, describes the types of Cyclooxygenase 2 Inhibitor market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cyclooxygenase 2 Inhibitor market and the development prospects and opportunities of Cyclooxygenase 2 Inhibitor industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cyclooxygenase 2 Inhibitor market in Chapter 13.
By Player:
Bayer
Teva Pharmaceutical
Mylan
Merck
Aurobindo Pharma
Torrent Pharmaceuticals
Cipla
Sabinsa
Alembic Pharmaceutical
Cadila Pharmaceuticals
Pfizer
Novartis
By Type:
Selective Cox 2 Inhibitor
Non-Selective Cox 2 Inhibitor
By End-User:
Hospital
Specialty Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cyclooxygenase 2 Inhibitor Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cyclooxygenase 2 Inhibitor Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cyclooxygenase 2 Inhibitor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cyclooxygenase 2 Inhibitor Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cyclooxygenase 2 Inhibitor Market Analysis and Outlook to 2022
-
7.1 Global Cyclooxygenase 2 Inhibitor Consumption (2017-2022)
-
7.2 United States Cyclooxygenase 2 Inhibitor Consumption (2017-2022)
-
7.3 Europe Cyclooxygenase 2 Inhibitor Consumption (2017-2022)
-
7.4 China Cyclooxygenase 2 Inhibitor Consumption (2017-2022)
-
7.5 Japan Cyclooxygenase 2 Inhibitor Consumption (2017-2022)
-
7.6 India Cyclooxygenase 2 Inhibitor Consumption (2017-2022)
-
7.7 South Korea Cyclooxygenase 2 Inhibitor Consumption (2017-2022)
8 Region and Country-wise Cyclooxygenase 2 Inhibitor Market Analysis and Outlook to 2028
-
8.1 Global Cyclooxygenase 2 Inhibitor Consumption Forecast (2022-2028)
-
8.2 United States Cyclooxygenase 2 Inhibitor Consumption Forecast (2022-2028)
-
8.3 Europe Cyclooxygenase 2 Inhibitor Consumption Forecast (2022-2028)
-
8.4 China Cyclooxygenase 2 Inhibitor Consumption Forecast (2022-2028)
-
8.5 Japan Cyclooxygenase 2 Inhibitor Consumption Forecast (2022-2028)
-
8.6 India Cyclooxygenase 2 Inhibitor Consumption Forecast (2022-2028)
-
8.7 South Korea Cyclooxygenase 2 Inhibitor Consumption Forecast (2022-2028)
9 Global Cyclooxygenase 2 Inhibitor Market Outlook by Types and Applications to 2022
-
9.1 Global Cyclooxygenase 2 Inhibitor Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Selective Cox 2 Inhibitor Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Non-Selective Cox 2 Inhibitor Consumption and Growth Rate (2017-2022)
-
9.2 Global Cyclooxygenase 2 Inhibitor Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Specialty Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Cyclooxygenase 2 Inhibitor Market Outlook by Types and Applications to 2028
-
10.1 Global Cyclooxygenase 2 Inhibitor Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Selective Cox 2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Non-Selective Cox 2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cyclooxygenase 2 Inhibitor Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Specialty Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Cyclooxygenase 2 Inhibitor Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cyclooxygenase 2 Inhibitor Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cyclooxygenase 2 Inhibitor Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cyclooxygenase 2 Inhibitor Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cyclooxygenase 2 Inhibitor Market Competitive Analysis
-
14.1 Bayer
-
14.1.1 Bayer Company Details
-
14.1.2 Bayer Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bayer Cyclooxygenase 2 Inhibitor Product and Service
-
14.2 Teva Pharmaceutical
-
14.2.1 Teva Pharmaceutical Company Details
-
14.2.2 Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Product and Service
-
14.3 Mylan
-
14.3.1 Mylan Company Details
-
14.3.2 Mylan Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Mylan Cyclooxygenase 2 Inhibitor Product and Service
-
14.4 Merck
-
14.4.1 Merck Company Details
-
14.4.2 Merck Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck Cyclooxygenase 2 Inhibitor Product and Service
-
14.5 Aurobindo Pharma
-
14.5.1 Aurobindo Pharma Company Details
-
14.5.2 Aurobindo Pharma Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Aurobindo Pharma Cyclooxygenase 2 Inhibitor Product and Service
-
14.6 Torrent Pharmaceuticals
-
14.6.1 Torrent Pharmaceuticals Company Details
-
14.6.2 Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Product and Service
-
14.7 Cipla
-
14.7.1 Cipla Company Details
-
14.7.2 Cipla Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Cipla Cyclooxygenase 2 Inhibitor Product and Service
-
14.8 Sabinsa
-
14.8.1 Sabinsa Company Details
-
14.8.2 Sabinsa Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sabinsa Cyclooxygenase 2 Inhibitor Product and Service
-
14.9 Alembic Pharmaceutical
-
14.9.1 Alembic Pharmaceutical Company Details
-
14.9.2 Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Product and Service
-
14.10 Cadila Pharmaceuticals
-
14.10.1 Cadila Pharmaceuticals Company Details
-
14.10.2 Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Product and Service
-
14.11 Pfizer
-
14.11.1 Pfizer Company Details
-
14.11.2 Pfizer Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Pfizer Cyclooxygenase 2 Inhibitor Product and Service
-
14.12 Novartis
-
14.12.1 Novartis Company Details
-
14.12.2 Novartis Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Novartis Cyclooxygenase 2 Inhibitor Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cyclooxygenase 2 Inhibitor
-
Figure Cyclooxygenase 2 Inhibitor Picture
-
Table Global Cyclooxygenase 2 Inhibitor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cyclooxygenase 2 Inhibitor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cyclooxygenase 2 Inhibitor Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cyclooxygenase 2 Inhibitor Consumption by Country (2017-2022)
-
Figure United States Cyclooxygenase 2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Table Europe Cyclooxygenase 2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure China Cyclooxygenase 2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Japan Cyclooxygenase 2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure India Cyclooxygenase 2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cyclooxygenase 2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Cyclooxygenase 2 Inhibitor Consumption Forecast by Country (2022-2028)
-
Figure United States Cyclooxygenase 2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cyclooxygenase 2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cyclooxygenase 2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cyclooxygenase 2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cyclooxygenase 2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cyclooxygenase 2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Selective Cox 2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Selective Cox 2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Specialty Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Selective Cox 2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-Selective Cox 2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Specialty Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cyclooxygenase 2 Inhibitor Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cyclooxygenase 2 Inhibitor Export by Region (Top 5 Countries) (2017-2028)
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Cyclooxygenase 2 Inhibitor Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Cyclooxygenase 2 Inhibitor Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Cyclooxygenase 2 Inhibitor Product and Service
-
Table Aurobindo Pharma (Foundation Year, Company Profile and etc.)
-
Table Aurobindo Pharma Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo Pharma Cyclooxygenase 2 Inhibitor Product and Service
-
Table Torrent Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Product and Service
-
Table Cipla (Foundation Year, Company Profile and etc.)
-
Table Cipla Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Cyclooxygenase 2 Inhibitor Product and Service
-
Table Sabinsa (Foundation Year, Company Profile and etc.)
-
Table Sabinsa Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sabinsa Cyclooxygenase 2 Inhibitor Product and Service
-
Table Alembic Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Product and Service
-
Table Cadila Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Cyclooxygenase 2 Inhibitor Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Cyclooxygenase 2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Cyclooxygenase 2 Inhibitor Product and Service
-
